Link Pharma Chem sets Aug 20 for 41st AGM; urges KYC updates

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Link Pharma Chem Limited has announced its 41st Annual General Meeting for August 20, 2026, conducted via VC/OAVM. Key agenda items include the adoption of FY26 financial statements, re-appointment of Satish Thakur as director, and ratification of cost auditor remuneration. The company also highlighted the importance of updating KYC details for physical shareholders to comply with SEBI regulations and ensure electronic dividend payments.

powered bylight_fuzz_icon
46694258

*this image is generated using AI for illustrative purposes only.

Link Pharma Chem has scheduled its 41st Annual General Meeting (AGM) for Thursday, August 20, 2026, to be conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The meeting will transact ordinary business, including the adoption of audited financial statements for FY26, and special business such as the ratification of cost auditor remuneration and the appointment of secretarial auditors. Shareholders holding securities as of the record date will be eligible to vote electronically during the designated window, ensuring their voice is heard on key governance matters.

The company has fixed August 13, 2026, as the cut-off date for determining shareholder eligibility. Consequently, the Register of Members and Share Transfer Books will remain closed from August 14 to August 20, 2026, in compliance with Section 91 of the Companies Act, 2013, and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This procedural step ensures that only shareholders holding securities on the record date can participate in the virtual meeting.

E-Voting and Meeting Schedule

Shareholders are required to complete their e-voting between August 17 and August 19, 2026. The remote e-voting window opens on Monday, August 17, at 9:00 a.m. and closes on Wednesday, August 19, at 5:00 p.m. The AGM itself commences at 11:30 a.m. IST on August 20. Participants can join the VC/OAVM session via InstaMeet, with login facilities opening 30 minutes prior to the scheduled start time. MUFG India Private Limited (formerly Link Intime India Private Limited) is providing the e-voting services.

Event Date/Period
Record Date for E-Voting August 13, 2026
Book Closure Period August 14–20, 2026
E-Voting Window August 17–19, 2026
AGM Date August 20, 2026

Agenda and Regulatory Compliance

The primary objective of the gathering is to consider and adopt the Audited Financial Statements for the financial year ended March 31, 2026. Additionally, shareholders will vote on the re-appointment of Satish Thakur as a director, who retires by rotation and offers himself for re-election.

Special business items include the ratification of remuneration for Cost Auditors M/s. Y. S. Thakar & Co., appointed to audit cost records for FY27. Their proposed remuneration is ₹45,000 per annum plus applicable taxes and reimbursement of actual out-of-pocket expenses. Furthermore, the meeting seeks approval for the appointment of Vijay Bhatt & Co., Practicing Company Secretaries, as Secretarial Auditors for a four-year term from FY27 to FY30, aligning with Section 204 of the Companies Act, 2013, and Regulation 24A of the SEBI Listing Regulations. The company has appointed Komal Bhojwani, Company Secretary & Compliance Officer, to oversee the compliance aspects of the meeting.

KYC Update Reminder for Physical Holders

In a separate communication dated July 28, 2026, the company reminded shareholders holding physical securities to update their Know Your Customer (KYC) details pursuant to SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 dated May 07, 2024. The circular mandates that security holders must record PAN, Address with PIN code, Mobile Number, Bank Account details, Specimen Signature, and choice of Nomination.

Failure to update these details may impact payment eligibility. As per the circular, security holders whose folios lack updated PAN, nomination, contact details, bank account details, or specimen signatures will only be eligible for payments, including dividends, through electronic mode with effect from April 1, 2024. The company encourages all physical holders to dematerialise their securities and register email IDs to avail online services.

Historical Stock Returns for Link Pharma Chem

1 Day5 Days1 Month6 Months1 Year5 Years
+1.48%+3.05%+0.51%-7.43%-20.26%-16.72%

How might the adoption of FY26 financial results influence Link Pharma Chem's dividend payout ratio or stock valuation in the coming quarter?

What strategic implications does the four-year appointment of secretarial auditors have for the company's long-term governance and compliance framework?

Could the re-election of Satish Thakur signal any shifts in corporate strategy or leadership continuity for Link Pharma Chem?

Link Pharma Chem re-appoints Satish Thakur as Chairman

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Link Pharma Chem Limited will re-appoint Mr. Satish G. Thakur as Chairman and Whole-time Director for a three-year term effective June 24, 2026, pending shareholder approval. Mr. Thakur, the father of the Managing Director, has over 43 years of experience and has been with the company since its inception.

powered bylight_fuzz_icon
41146199

*this image is generated using AI for illustrative purposes only.

Link Pharma Chem Limited has announced the re-appointment of Mr. Satish G. Thakur as Chairman and Whole-time Director of the company. The decision is subject to the approval of shareholders at the ensuing Annual General Meeting. The disclosure was made in compliance with SEBI regulations.

Mr. Thakur is scheduled to assume office on June 24, 2026. His tenure will extend for a period of three years from the date of appointment. He has been associated with link pharma chem since its incorporation and holds a B.Sc. and L.Tech degree.

The director brings extensive experience to the role, with over 43 years in the industry. His expertise includes project design and development. He has been involved in the operations of the company since its inception.

Key Appointment Details

Sr. No. Disclosure Requirement Details
01. Reason for change Re-appointment of Mr. Satish G Thakur (DIN: 00292129) as Chairman and Whole-time Director.
02. Date of appointment & term June 24, 2026, for a period of 3 years subject to shareholder approval.
03. Brief profile Associated with the company since incorporation; holds B.Sc., L.Tech; over 43 years of experience.
04. Relationship Father of Mr. Rishikesh Thakur, Managing Director.

The company's registered office is located at Plot No. 162, G.I.D.C., Nandesari - 391340, Dist. Vadodara (Gujarat).

Historical Stock Returns for Link Pharma Chem

1 Day5 Days1 Month6 Months1 Year5 Years
+1.48%+3.05%+0.51%-7.43%-20.26%-16.72%

How might the dual family leadership structure, with Mr. Satish Thakur as Chairman and his son Mr. Rishikesh Thakur as Managing Director, influence corporate governance practices and minority shareholder confidence at Link Pharma Chem?

What strategic initiatives or expansion plans could Mr. Thakur prioritize during his 2026-2029 tenure given the evolving competitive landscape in the Indian pharmaceutical chemicals sector?

How are institutional investors and proxy advisory firms likely to respond to the shareholder vote on this re-appointment, particularly given increasing scrutiny of family-controlled pharma companies in India?

More News on Link Pharma Chem

1 Year Returns:-20.26%